1 report

PRIOR RESEARCH FOCUS ON INSULIN RESISTANCE IS GRADUALLY SHIFTING TO SECRETION IMPAIRMENT, AND HOPEFULLY BETTER TREATMENT OPTIONS FOR T##D WILL ADDRESS THE Β-CELL PATHOLOGY.

  • Antimalarials
  • Western Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.